Prognostic comparison between pulmonary metastasectomy and combination immunotherapy with targeted molecular therapies for advanced hepatocellular carcinoma with pulmonary metastasis:A propensity score matching analysis
Juxian Sun Chang Liu Xiandong Tao Yu Yang Hai Jin Shuqun Cheng Huazheng Shi Maolin Yan Jie Shi
肝脏研究(英文)2025,Vol.9Issue(1):29-35,7.
肝脏研究(英文)2025,Vol.9Issue(1):29-35,7.DOI:10.1016/j.livres.2025.01.006
Prognostic comparison between pulmonary metastasectomy and combination immunotherapy with targeted molecular therapies for advanced hepatocellular carcinoma with pulmonary metastasis:A propensity score matching analysis
Prognostic comparison between pulmonary metastasectomy and combination immunotherapy with targeted molecular therapies for advanced hepatocellular carcinoma with pulmonary metastasis:A propensity score matching analysis
摘要
关键词
Hepatocellular carcinoma(HCC)/Pulmonary metastasis(PM)/Pulmonary metastasectomy/Immunotherapy/Targeted therapyKey words
Hepatocellular carcinoma(HCC)/Pulmonary metastasis(PM)/Pulmonary metastasectomy/Immunotherapy/Targeted therapy引用本文复制引用
Juxian Sun,Chang Liu,Xiandong Tao,Yu Yang,Hai Jin,Shuqun Cheng,Huazheng Shi,Maolin Yan,Jie Shi..Prognostic comparison between pulmonary metastasectomy and combination immunotherapy with targeted molecular therapies for advanced hepatocellular carcinoma with pulmonary metastasis:A propensity score matching analysis[J].肝脏研究(英文),2025,9(1):29-35,7.基金项目
This work is supported by the School-level project of Naval Medical University(No.2022MS038) (No.2022MS038)
National Natural Science Foundation of China(No.82073293) (No.82073293)
National Key R&D Program of China(No.2022YFC2503700). (No.2022YFC2503700)